• 1
    Carpenter G, Lemback KJ, Morrison MM, Cohen S. Characterization of the binding of 125I-labeled epidermal growth factor to human fibroblasts. J Biol Chem 1975; 250: 42974304.
  • 2
    Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem 1979; 48: 193216.
  • 3
    Merlino GT, Xu YH, Richart N et al. Elevated epidermal growth factor receptor gene copy number and expression in a squamous carcinoma cell line. J Clin Invest 1985; 75: 10771079.
  • 4
    Hendler FJ, Ozanne BW. Human squamous lung cancers express increased epidermal growth factor receptors. J Clin Invest 1984; 74: 647651.
  • 5
    Gullick WJ, Marsden JJ, Whittle N, Ward B, Bobrow L, Water-field MD. Expression of epidermal growth factor receptors on human cervical, ovarian and vulval carcinomas. Cancer Res 1986; 46: 285292.
  • 6
    Pfeiffer D, Stellwag B, Pfeiffer A, Borlinghaus P, Meier W, Scheidel P. Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1989; 33: 146150.
  • 7
    Berchuck A, Rodriguez G, Kamel A, Soper JD, Clarke-Pearson DL, Bast RC. Expression of epidermal growth factor receptor and HER-2/ neu in normal and neoplastic cervix, vulva and vagina. Obstet Gynecol 1990; 76: 381387.
  • 8
    Kato H, Miyauchi F, Morioka H, Fujino T, Torigoe T. Tumor antigen of human cervical squamous cell carcinoma: Correlation of circulating levels with disease progress. Cancer 1979; 43: 585590.
  • 9
    Maruo T, Shibata K, Kimura A, Hoshina M, Mochizuki M. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix: Serial determinations and tissue localization. Cancer 1985; 56: 302308.
  • 10
    Hoshina M, Kimura A, Shibata K, Maruo T, Mochizuki M. Immunocytological distribution of the tumor antigen TA-4: Ex pression during carcinogenesis and maturation of squamous epithelium of human uterine cervix. Asia Oceania J Obstet Gynaecol 1986; 12: 119126.
  • 11
    Hussa RO, Maruo T, Strobel JL, Pattillo RA, Mochizuki M. Production of tumor-associated antigen, TA-4, by CaSki cervical carcinoma cell line. Obstet Gynecol 1986; 67: 802805.
  • 12
    Maruo T, Matsuo H, Nishino R et al. Discordant induction of tumor-associated antigen, TA-4 and chorionic gonadotropin β in cultured cervical carcinoma cells. Acta Obstet Gynaecol Jpn 1987; 39: 291296.
  • 13
    Novak ER, Woodruff JD. Novak's Gynecologic and Obstetric Pathology. Philadelphia: W.B. Saunders, 1979; 111156.
  • 14
    Maruo T, Mochizuki M. Immunohistochemical localization of epidermal growth factor receptor and myc oncogene product in human placenta: Implication for trophoblast proliferation and differentiation. Am J Obstet Gynecol 1987; 156: 721727.
  • 15
    DePalo L, Das M. Epidermal growth factor-induced stimulation of epidermal growth factor receptor synthesis in human cytotrophoblasts and A431 carcinoma cells. Cancer Res 1988; 48: 11051109.
  • 16
    Jakobovits EG, Majors JE, Varmus HE. Hormonal regulation of the Rous sarcoma src gene via a heterologous promoter defines a threshold dose for cellular transformation. Cell 1984; 38: 757765.
  • 17
    Downward J, Yarden Y, Mayes E et al. Close similarity of the epidermal growth factor receptor and v- erb B oncogene protein sequence. Nature 1984; 307: 521527.